J&J-backed Cellular Origins raises $40M for cell therapy manufacturing

J&J-backed Cellular Origins raises $40M for cell therapy manufacturing

UK-based cell therapy manufacturer Cellular Origins has raised $40 million in an over-subscribed Series A to expand to the US and secure more company partnerships. The round was led by Johnson & Johnson’s venture capital ...

Cellular Origins secures major CGT funding breakthrough - European Biotechnology Magazine

UK-bad Cellular Origins Ltd raised $40m to scale global CGT manufacturing with robotic automation, boosting access to cell therapies and enabling commercial growth. Cellular Origins raises $40M to scale global CGT manufacturing with robotic automation, boosting access to cell therapies and enabling commercial growth.